AG00BE90

20744-51-8 | Tobramycin A

Chemical structure of Tobramycin A, CAS 20744-51-8
AG00BE90
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 20744-51-8
Catalog Number AG00BE90(AGN-PC-0QWI9E)
Chemical Name Tobramycin A
IUPAC Name (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol
InChI InChI=1S/C12H25N3O7/c13-3-1-4(14)11(10(20)7(3)17)22-12-9(19)6(15)8(18)5(2-16)21-12/h3-12,16-20H,1-2,13-15H2/t3-,4+,5+,6-,7+,8+,9+,10-,11-,12+/m0/s1
InChI Key WPYNTQYMFOTKRF-OSDBSAJISA-N
MDL Number MFCD01939977
Molecular Formula C12H25N3O7
Molecular Weight 323.3428
SMILES N[C@H]1C[C@@H](N)[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](N)[C@H]2O)[C@@H](O)[C@@H]1O
Synonyms
20744-51-8, Antibiotic NK 1012-2, Deoxystreptamine-kanosaminide, BRN 0026899, NK-1012-2, Streptamine, 4-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy-, L-, AC1L4NLP, Tobramycin rings B and C, AC1Q55IV, (1s,2s,3r,4s,6r)-4,6-diamino-2,3-dihydroxycyclohexyl 3-amino-3-deoxy-|A-d-glucopyranoside, Kanamycin A Related Compound 2, C12H25N3O7, ZINC5426353, D-Streptamine, 6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy-, D-Streptamine, 6-O-(3-amino-3-deoxy-alpha-D-glucopyranosyl)-2-deoxy- (9CI), LS-146920, Z1881, 6-o-(3-Amino-3-deoxy-alpha-D-deoxyglucopyranosyl)-2-deoxy-streptamine, (2S,3R,4S,5S,6R)-4-amino-2-((1S,2S,3R,4S,6R)-4,6-diamino-2,3-dihydroxycyclohexyloxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol, (2S,3R,4S,5S,6R)-4-amino-2-[(1S,2S,3R,4S,6R)-4,6-diamino-2,3-dihydroxycyclohexyl]oxy-6-(hydroxymethyl)oxane-3,5-diol, TOBRAMYCINA, KST-1A5623, AR-1A1526, CID209916, C12-H25-N3-O7, 4-18-00-07631 (Beilstein Handbook Reference), 5410-42-4,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited